Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Don't expect Johnson & Johnson's COVID vaccine to quickly lift U.S. supplies. Early shipments will be small, officials say
Anthem, CloudMedx bringing COVID-19 tracking tool to vaccine distribution
Everlywell’s home COVID-19 testing kit goes direct-to-consumer
Bring on the boosters: Studies show Pfizer, Moderna COVID vaccines are less potent against aggressive variant
Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot production
Businesses, public health organizations form alliance to strengthen COVID-19 response
Amid AstraZeneca supply kerfuffle, Belgian plant blamed for shortfalls 'drastically' boosts capacity: report
Uninsured rates among young people dropped under ACA: Urban Institute

Featured Story

Don't expect Johnson & Johnson's COVID vaccine to quickly lift U.S. supplies. Early shipments will be small, officials say

By Eric Sagonowsky

Johnson & Johnson's easier-to-use, single-dose COVID-19 vaccine is nearing authorization, theoretically promising a major boost to the frantic U.S. immunization campaign. But J&J only has "a few million" doses ready to deliver right away, a White House advisor said Wednesday.

Anthem, CloudMedx bringing COVID-19 tracking tool to vaccine distribution

By Paige Minemyer

Anthem and CloudMedx are adding vaccine distribution data to their online COVID-19 data platform.

Everlywell’s home COVID-19 testing kit goes direct-to-consumer

By Conor Hale

Everlywell’s home testing kit for COVID-19—first authorized by the FDA last year, for use with a doctor’s prescription—will now be available for sale directly to the consumer, through online orders or retail store shelves.

Bring on the boosters: Studies show Pfizer, Moderna COVID vaccines are less potent against aggressive variant

By Arlene Weintraub

In letters published in the New England Journal of Medicine, Pfizer and Moderna acknowledged that laboratory experiments showed their mRNA vaccines aren't as potent against the aggressive new COVID-19 variant identified in South Africa. Wall Street analysts are worried.

Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot production

By Kevin Dunleavy

While Mexico is receiving small shipments of AstraZeneca's COVID-19 vaccines from overseas, two large shipments of the active ingredient used to make it remain unused. The holdup? Problems at a domestic factory tasked with finishing the shots, according to Mexico’s foreign minister Marcelo Ebrard.

COVID-19 Tracker

Featured Story

Don't expect Johnson & Johnson's COVID vaccine to quickly lift U.S. supplies. Early shipments will be small, officials say

Top Stories

Anthem, CloudMedx bringing COVID-19 tracking tool to vaccine distribution

Everlywell’s home COVID-19 testing kit goes direct-to-consumer

Bring on the boosters: Studies show Pfizer, Moderna COVID vaccines are less potent against aggressive variant

Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot production

Businesses, public health organizations form alliance to strengthen COVID-19 response

Amid AstraZeneca supply kerfuffle, Belgian plant blamed for shortfalls 'drastically' boosts capacity: report

Uninsured rates among young people dropped under ACA: Urban Institute